Vargas RM, Ríos NL, Salazar LMA, Cano F

Language: Spanish
References: 13
Page: 219-225
PDF size: 102.42 Kb.

ABSTRACT

Objective: The aim was outlining the total cost of lung tuberculosis treatment in the National Institute of Respiratory Diseases during 2002. Methods: The total cost of lung tuberculosis treatment was determined through a transversal-retrospective study. The costing of type cases was made as well as a sample, in order to obtain comparable information of the costs and interventions realized. There were also identified socio-demographic characteristics of the attended population. Results: The attention cost of a non-complicated pulmonary tuberculosis patient was of $3,892 US Cy. and the patients with complications, $17,952 US Cy. The 62% were non-complicated cases and required an average of 14 days of hospitalization. The cost of hospitalization (cost per day) was the greatest percent of medical attention cost and the bronchial arteries embolism the second one. Characterization of population: the 62% of patients were male; the 66% came from Mexico City and Estado de Mexico; the 68% of patients was in the 21-60 years interval; the 63% was located in the lowest socio-economic levels. Conclusion: Tuberculosis is going to be held present in Mexico as it is an infectious disease associated with poverty. As long as the increment in the incidence of TB-HIV co-infection continues, and the drug-resistance cases (as a result of the treatment characteristics) tuberculosis will continue being a health problem at INER, with the inherent increase of resources assigned for its attention.

REFERENCES

1. Kumate J, Onofre-Muñoz, Gutiérrez G, Santos JI. Manual de infectología. 16a ed. México, DF: Méndez editores, 2001:40.

2. Lugo G. Bacteriología médica. México, DF: Ediciones Cuellar, 1998:165-195.

3. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report 2003. WHO/CDS/Tuberculosis/2003.316.

4. Zavala D. Situación de la asociación Tuberculosis-VIH/SIDA (Región de las Américas). Programa Regional de Tuberculosis. Programa de Entrenamiento en Tuberculosis OPS-USAID. OMS: Agosto, 2003.

5. Secretaría de Salud. Archivo Clínico del Instituto Nacional de Enfermedades Respiratorias. México, DF, 2002.

6. Día Mundial de la Tuberculosis. OPS/OMS/HCP/HCT/TUB. Vol. 5, No. 1. Febrero 2002. Disponible en: http://www.paho.org/Spanish/AD/DPC/CD/Tuberculosis-boletin-2002-1.pdf

7. Modificación a la Norma Oficial Mexicana NOM-006-SSA2-1993, para la prevención y control de la Tuberculosis en la atención primaria a la salud. Secretaría de Salud. México, 2000.

8. Norma Oficial Mexicana NOM-006-SSA2-1993, para la prevención y control de la Tuberculosis en la atención primaria de la salud. Secretaría de Salud. México, 1994.

9. OPS. Informe de la reunión de los jefes de programas de control de la Tuberculosis. OPS/OMS. Cuba: septiembre, 2002. Disponible en: http://www.paho.org/Spanish/AD/DPC/CD/Tuberculosis-reunion-pnt-habana-2002-inf.pdf

10. Tablas estadísticas, Tuberculosis en las Américas: Incidencia, Programas Nacionales, Cobertura de DOTS. OPS. 2002. Disponible en: http://www.paho.org/Spanish/AD/DPC/CD/Tuberculosis-data.htm

11. Larson H, Mahanty B. Build a Case for Stronger Action to Stop Tuberculosis. Guidelines for Social Mobilization. Planning World Tuberculosis Day WHO: 2000.

12. Secretaría de Salud. La Tuberculosis causa tres millones de muertes al año en el mundo. Comunicado de prensa No. 205. México, 2001.

13. Cano VF. Programa de Trabajo 2003-2008. Junta de Gobierno del Instituto Nacional de Enfermedades Respiratorias. México, DF, 2003.